Migros Group intends to sell Gowoonsesang to L’Oréal, enhancing the latter's presence in the Korean beauty sector while providing Gowoonsesang with opportunities for global expansion.
Information on the Target
Gowoonsesang Cosmetics Co. Ltd., established in 1998, specializes in providing a diverse array of cosmetic products tailored for sensitive skin. Acquired by the Mibelle Group in 2018, Gowoonsesang is renowned for its flagship brand, Dr.G, which stands as one of South Korea's top dermocosmetic brands. The company also manages other notable brands, including vividraw, Lab.it, and Heal us. Employing approximately 200 individuals in South Korea and around 10 in China, Gowoonsesang exports its products to more than ten countries across the Asia-Pacific region and the United States.
Industry Overview in South Korea
The South Korean beauty industry is a dynamic and rapidly evolving sector, recognized globally for its innovation and trend-setting products. The country has become a leading hub for beauty brands, catering to a diverse consumer base that prioritizes skincare and cosmetic efficacy. With a cultural emphasis on beauty and personal care, South Korea has witnessed consistent growth in market demand, driven by aesthetic trends and the increasing popularity of Korean beauty (K-beauty) worldwide.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
In recent years, the Korean beauty market has expanded significantly, with a notable rise in the exportation of K-beauty products around the globe. This growth has further spurred domestic companies to enhanc
Similar Deals
Hiltz Capital Management → Crestline Bagel Company
2025
L’Oréal
invested in
Gowoonsesang Cosmetics
in 2024
in a Buyout deal